The global spirometer market size was valued at USD 674.38 million in 2025 and is projected to grow from USD 711.47 million in 2026 to USD 1091.88 million by 2034, registering a CAGR of 5.5% during the forecast period from 2026 to 2034. North America dominated the spirometer market with a market share of 38.4% in 2025.
A spirometer is a medical device used to measure how much air a person can inhale and exhale and how quickly air can be expelled from the lungs. It is commonly used as part of pulmonary function testing to assess breathing and lung function. During the test, the individual breathes through a mouthpiece connected to the device while the spirometer records measurements such as forced vital capacity and forced expiratory volume. Healthcare professionals can use these results to help evaluate and monitor conditions that affect airflow and lung capacity, as well as to assess changes in respiratory function over time. Spirometers are available in various forms, including portable and computerized devices used in hospitals, clinics, and other healthcare settings.
Download a Free Sample To learn more about this report,
Digital Spirometry Improves Respiratory Testing and Patient Monitoring
The spirometer market is increasingly moving toward digital and connected devices that make lung-function testing easier to perform and record. Modern spirometers can provide automated measurements, digital displays, data storage, and connectivity with healthcare software, helping clinicians monitor respiratory conditions more efficiently. These capabilities are particularly useful for diagnosing and managing conditions such as asthma and chronic obstructive pulmonary disease, while also supporting more convenient testing in clinics and other healthcare settings.
In March 2025, MIR expanded its digital respiratory diagnostic portfolio with connected spirometry solutions designed to simplify pulmonary function testing and data management. The development supports healthcare professionals in capturing and reviewing respiratory measurements through more connected diagnostic workflows.
Portable Spirometers Expand Respiratory Testing Beyond Hospitals
The spirometer market is also benefiting from the growing use of compact and portable devices. Smaller spirometers allow respiratory testing to be carried out in primary-care clinics, community healthcare settings, occupational health programmes, and potentially at home under appropriate clinical supervision. Portable systems can make testing more convenient for patients while helping healthcare professionals monitor lung function without relying entirely on larger laboratory-based equipment.
In September 2025, Vitalograph expanded its range of portable spirometry solutions for respiratory assessment, focusing on compact devices that can support pulmonary function testing in different clinical environments. The development reflects the broader shift toward accessible and flexible respiratory diagnostics.
Rising Prevalence of Respiratory Diseases and Growing Need for Lung Function Testing
The spirometer market is being driven by the growing burden of respiratory conditions such as chronic obstructive pulmonary disease, asthma, and other disorders that require pulmonary function assessment. Spirometry is widely used to measure lung function and support diagnosis, monitoring, and treatment decisions. Increasing awareness of early respiratory disease detection and the need for regular monitoring are strengthening spirometer market demand and influencing spirometer market trends toward portable, digital, and connected testing devices.
In May 2025, the World Health Organization highlighted that chronic respiratory diseases remain a major global health burden and emphasized the importance of early diagnosis and access to appropriate treatment. The organization identified chronic obstructive pulmonary disease and asthma among the most common chronic respiratory conditions, supporting the continued need for accessible lung-function assessment.
Requirement for Skilled Testing and Proper Patient Technique
The market faces restraints because accurate spirometry depends heavily on appropriate patient cooperation, correct breathing technique, equipment calibration, and proper test administration. Poor effort, incorrect positioning, coughing, leaks, or inadequate coaching can affect test quality and lead to unreliable results. Healthcare professionals therefore require appropriate training to conduct and interpret testing correctly. These requirements create spirometer industry challenges and can influence spirometer market development, particularly in primary-care facilities and regions with limited pulmonary-function expertise.
In February 2025, the American Thoracic Society and European Respiratory Society continued emphasizing standardized approaches to pulmonary function testing, including appropriate equipment quality, test performance, acceptability, and repeatability. The guidance highlighted the importance of trained personnel and standardized procedures for obtaining reliable lung-function measurements.
Expansion of Portable and Home-Based Respiratory Monitoring
The market presents significant opportunities through compact spirometers, handheld devices, Bluetooth-enabled systems, mobile applications, and remote patient monitoring platforms. Portable technologies can make lung-function assessment more accessible outside specialized pulmonary laboratories and can support monitoring in primary care, occupational health, home settings, and telehealth programs. The growing use of connected medical devices is creating new spirometer market opportunities and supporting spirometer market growth as healthcare providers seek more convenient methods for tracking respiratory health.
In March 2026, the U.S. Food and Drug Administration continued clearing connected pulmonary-function devices that combine spirometry measurements with digital data management and wireless connectivity. These developments demonstrate the industry's movement toward portable respiratory testing and greater integration between diagnostic devices and digital healthcare workflows.
Ensuring Measurement Accuracy and Device Reliability Across Different Settings
The spirometer market continues to face challenges in maintaining consistent measurement accuracy across hospitals, clinics, occupational-health facilities, and home environments. Devices must provide reliable measurements despite differences in patient technique, environmental conditions, calibration practices, and maintenance procedures. Digital and connected systems also require secure handling of patient information and dependable data transmission. These considerations are shaping the spirometer market outlook and encouraging manufacturers to improve sensor technology, automated quality checks, calibration systems, connectivity, and user guidance.
In January 2026, the U.S. National Institute for Occupational Safety and Health continued emphasizing quality assurance requirements for spirometry programs used in occupational settings, including equipment calibration, technician training, testing procedures, and quality control. The continued focus on standardized testing demonstrates the importance of reliable measurements for respiratory health assessment.
Hand-Held Segment Dominated the Spirometer Market with 61.7% Share in 2025
The hand-held segment dominated the global spirometer market with a 61.7% share in 2025, driven by the portability, ease of use, and convenient operation of compact respiratory testing devices. Hand-held spirometers can be used across hospitals, clinics, diagnostic facilities, and increasingly outside traditional clinical environments. Growing demand for accessible respiratory assessment and the development of compact digital diagnostic devices are supporting adoption.
Tabletop spirometers continue to serve healthcare facilities that require more comprehensive respiratory testing capabilities and stable clinical workstation setups. Their continued use in hospitals, pulmonary clinics, and diagnostic centers supports demand for larger and more established spirometry systems.
Request Customizationto receive a tailored report.
Flow Measurement Segment is Projected to Register the Fastest Growth in the Spirometer Market at a CAGR of 10.2%
The flow measurement segment is projected to register the fastest growth in the global spirometer market at a CAGR of 10.2% during 2026–2034, driven by increasing demand for accurate and responsive measurement of airflow during pulmonary function testing. Flow-based technology supports the assessment of respiratory performance and can enable efficient monitoring of changes in lung function. Increasing adoption of digital respiratory diagnostic devices and growing emphasis on early respiratory assessment are supporting segment growth.
Volume measurement technology remains an important approach for evaluating lung capacity and respiratory performance. It continues to be used across clinical settings where reliable measurement of inhaled and exhaled air volumes is required.
COPD Segment Dominated the Spirometer Market with 48.6% Share in 2025
The COPD segment dominated the global spirometer market with a 48.6% share in 2025, driven by the important role of spirometry in evaluating airflow limitation and supporting the assessment and monitoring of chronic obstructive pulmonary disease. Increasing awareness of respiratory diseases and the growing need for regular pulmonary function assessment are supporting demand for spirometry devices. Rising focus on early detection and long-term respiratory monitoring is further contributing to market growth.
Asthma represents another important application as spirometry supports evaluation of lung function and monitoring of respiratory changes. Other applications include pulmonary function assessment across various respiratory conditions and clinical situations where objective measurement of breathing performance is required.
Home Care Settings Segment is Projected to Register the Fastest Growth in the Spirometer Market at a CAGR of 12.1%
The home care settings segment is projected to register the fastest growth in the global spirometer market at a CAGR of 12.1% during 2026–2034, driven by the increasing adoption of portable respiratory monitoring devices and the growing need for convenient long-term management of respiratory conditions. Home-based spirometry can support regular monitoring while reducing the need for frequent visits to healthcare facilities. Advances in connected and user-friendly respiratory devices are further supporting adoption in home care environments.
Hospitals and clinics remain the primary end users because they provide comprehensive diagnostic facilities and access to trained healthcare professionals for pulmonary function testing. Other end users, including diagnostic centers and specialized healthcare facilities, continue to utilize spirometers for respiratory assessment, screening, and patient monitoring.
Speak to an Analystto discuss market opportunities.
North America accounted for the largest share of the global spirometer market, representing 38.4% of total revenue and reaching USD 0.26 billion in 2025. The region is projected to grow at a CAGR of 8.9% during 2026–2034. Strong healthcare infrastructure, increasing prevalence of respiratory disorders, growing demand for pulmonary function testing, and wider adoption of portable diagnostic devices are supporting regional market growth. Rising awareness of early respiratory disease detection is also contributing to demand for spirometry equipment.
The US market was valued at approximately USD 0.22 billion in 2025, making it the largest contributor in North America. Strong healthcare infrastructure, increasing respiratory disease burden, and widespread use of pulmonary function testing are supporting market development. Growing adoption of compact and connected spirometry devices is also improving access to respiratory diagnostics.
Canada's market reached approximately USD 0.04 billion in 2025. Increasing demand for respiratory diagnostics, expanding healthcare services, and greater awareness of pulmonary function testing are supporting market growth. Adoption of portable diagnostic equipment is also contributing to market development.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific accounted for 22.8% of the global spirometer market, valued at USD 0.15 billion in 2025, and is projected to register the fastest CAGR of 11.8% during 2026–2034. Expanding healthcare infrastructure, increasing prevalence of respiratory conditions, improving access to diagnostic services, and growing healthcare expenditure are driving regional growth. Rising awareness of pulmonary testing and increasing adoption of portable medical devices are further supporting market expansion.
Japan's market generated approximately USD 0.03 billion in 2025. An advanced healthcare system, an aging population, and an increasing need for respiratory monitoring are supporting market development. The growing use of pulmonary function testing and technologically advanced diagnostic equipment is also contributing to demand.
China accounted for a major share of the Asia Pacific market, reaching approximately USD 0.07 billion in 2025. Expanding healthcare infrastructure, increasing respiratory disease awareness, and growing demand for diagnostic equipment are supporting market growth. Greater availability of pulmonary testing and increasing healthcare investment are also contributing to adoption.
Europe accounted for 27.6% of the global spirometer market, reaching USD 0.19 billion in 2025, and is projected to grow at a CAGR of 8.4% during 2026–2034. Strong healthcare systems, increasing prevalence of chronic respiratory diseases, and growing emphasis on early diagnosis are supporting regional growth. Continued adoption of advanced pulmonary function testing equipment is also contributing to market expansion.
The UK market was valued at approximately USD 0.03 billion in 2025. Growing demand for respiratory disease diagnosis, established healthcare services, and increasing focus on early detection are supporting market development. Greater adoption of digital and portable spirometry devices is also contributing to market growth.
Germany's market accounted for approximately USD 0.04 billion in 2025. Strong clinical infrastructure, increasing demand for pulmonary diagnostics, and growing awareness of respiratory health are supporting market development. The adoption of advanced spirometry systems in hospitals and diagnostic centres is also contributing to demand.
Latin America accounted for 6.4% of the global spirometer market, reaching USD 0.04 billion in 2025, and is projected to grow at a CAGR of 9.7% during 2026–2034. Improving healthcare infrastructure, rising awareness of respiratory diseases, and increasing access to diagnostic services are supporting regional development. Growing healthcare investment and wider availability of respiratory testing equipment are also creating opportunities for market growth.
Brazil's market was valued at approximately USD 0.02 billion in 2025. Expanding healthcare services, increasing demand for respiratory diagnostics, and growing awareness of chronic respiratory conditions are supporting market development. Greater access to pulmonary function testing is also contributing to adoption.
Mexico's market reached approximately USD 0.01 billion in 2025. Increasing healthcare investment, expanding diagnostic services, and rising awareness of respiratory health are supporting market growth. Growing availability of portable and affordable spirometry devices is also contributing to market development.
Middle East & Africa accounted for 4.8% of the global spirometer market, totalling USD 0.03 billion in 2025, and is projected to grow at a CAGR of 8.6% during 2026–2034. Improving healthcare infrastructure, increasing investment in diagnostic services, and rising awareness of respiratory diseases are supporting regional growth. Expanding hospital networks and greater access to pulmonary function testing are also contributing to market development.
The UAE market was valued at approximately USD 0.007 billion in 2025. Advanced healthcare infrastructure, increasing investment in diagnostic technologies, and growing demand for respiratory testing are supporting market development. Adoption of modern and portable pulmonary diagnostic devices is also contributing to market growth.
Africa's market reached approximately USD 0.023 billion in 2025. Expanding healthcare infrastructure, increasing access to diagnostic services, and growing awareness of respiratory conditions are supporting market development. Continued investment in medical equipment and improvements in pulmonary testing capabilities are expected to create further opportunities for spirometer adoption.
The global spirometer market is competitive, with medical device manufacturers developing pulmonary function testing equipment for hospitals, clinics, diagnostic laboratories, and respiratory care settings. The top players in the industry include SCHILLER, Hill-Rom, Inc., Midmark Corp., FutureMed, COSMED Srl, MGC Diagnostics Corporation, Smiths Medical, Vyaire Medical, Teleflex, NSPIRE HEALTH INC., and others.
Industry participants are focusing on making pulmonary function testing more accurate, portable, and easier to use in both clinical and outpatient settings. Companies are also developing digital spirometers with automated testing, improved patient guidance, data management, and connectivity features. The growing use of pulmonary function testing for conditions such as asthma, chronic obstructive pulmonary disease, and other respiratory disorders is encouraging manufacturers to improve device usability and testing workflows.
SCHILLER: An Emerging Market Player
SCHILLER is a prominent participant in the spirometer market, offering pulmonary function testing systems designed for respiratory diagnostics in clinical environments. Its respiratory portfolio includes spirometry and pulmonary function testing technologies that help healthcare professionals assess lung function and monitor respiratory health.
SCHILLER continues to develop pulmonary diagnostic solutions with an emphasis on accurate measurements, user-friendly workflows, and digital data management. Its spirovit SP-1 spirometer is designed for routine pulmonary function testing and provides measurements such as forced vital capacity and forced expiratory volume, supporting physicians in evaluating respiratory function and identifying changes in lung performance.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Medical Waste Containers Market Size, Share, Growth, Analysis, 2034
Hemostasis & Tissue Sealing Agents Market Size, Share, 2034
Assisted Walking Devices Market Size, Share, Growth, 2034
Defibrillator Market Size, Share, Growth, Analysis, Report, 2034
Vaginal Rejuvenation Market Size, Share, Growth, Report, 2034
Alpha Emitter Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com